First Published Case of Alzheimer’s Biomarker Reversal in a Chronic Lyme Disease Patient Using Dapsone Combination Therapy

B Peer-reviewed findings published in the Journal of Alzheimer’s Disease Reports show a 63% reduction in phosphorylated tau after a nine-week oral protocol HYDE PARK,…
posteditor
posteditor
Articles: 17424

Other News